If approved, it would represent yet another step forward in the GLP-1 receptor agonist family
Although semaglutide shows cardiometabolic benefits, its efficacy across CVD endpoints and high-risk CKD subgroups remains underexplored
Nutritional deficiencies due to appetite suppression Appetite reduction with semaglutide may affect overall nutrient intake, though clinical trials have not demonstrated consistent deficiencies in key fertility-related micronutrients such as folate, vitamin B12, iron, or vitamin D [13]
Best Patient Types for Microdose Peptide Therapy Microdosing is particularly well-suited for patients who are highly sensitive to exogenous hormones, individuals focused strictly on preventative longevity rather than acute rehabilitation, and patients transitioning off injectable hGH
It's important to note that weight loss itself is an evidence-based therapy for GERD, so the weight reduction achieved with these medications may actually improve reflux symptoms in some patients, potentially offsetting any direct effects on the gastroesophageal junction